These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22962091)

  • 21. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L; Giesa C; Ewig S
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
    Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
    Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
    Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does mid-regional pro-adrenomedullin (MR-proADM) improve the sequential organ failure assessment-score (SOFA score) for mortality-prediction in patients with acute infections? Results of a prospective observational study.
    Haag E; Gregoriano C; Molitor A; Kloter M; Kutz A; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 May; 59(6):1165-1176. PubMed ID: 33554514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection.
    Hartmann O; Schuetz P; Albrich WC; Anker SD; Mueller B; Schmidt T
    Int J Cardiol; 2012 Nov; 161(3):166-73. PubMed ID: 23017815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of mid-regional pro-adrenomedullin levels to cardiovascular and metabolic abnormalities, and mortality in an elderly population from the community.
    Eggers KM; Venge P; Lindahl B; Lind L
    Int J Cardiol; 2013 Oct; 168(4):3537-42. PubMed ID: 23722054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction.
    Elmas E; Lang S; Dempfle CE; Kälsch T; Papassotiriou J; Morgenthaler NG; Borggrefe M; Brueckmann M
    Int J Cardiol; 2008 Aug; 128(1):107-11. PubMed ID: 17698224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
    Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
    Gregoriano C; Koch D; Kutz A; Haubitz S; Conen A; Bernasconi L; Hammerer-Lercher A; Saeed K; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 Apr; 59(5):995-1004. PubMed ID: 33554516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department.
    Dieplinger B; Gegenhuber A; Kaar G; Poelz W; Haltmayer M; Mueller T
    Clin Biochem; 2010 Jun; 43(9):714-9. PubMed ID: 20153308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenomedullin optimises mortality prediction in COPD patients.
    Brusse-Keizer M; Zuur-Telgen M; van der Palen J; VanderValk P; Kerstjens H; Boersma W; Blasi F; Kostikas K; Milenkovic B; Tamm M; Stolz D
    Respir Med; 2015 Jun; 109(6):734-42. PubMed ID: 25937049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
    von Haehling S; Filippatos GS; Papassotiriou J; Cicoira M; Jankowska EA; Doehner W; Rozentryt P; Vassanelli C; Struck J; Banasiak W; Ponikowski P; Kremastinos D; Bergmann A; Morgenthaler NG; Anker SD
    Eur J Heart Fail; 2010 May; 12(5):484-91. PubMed ID: 20215339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precursors of adrenomedullin, endothelin and atrial natriuretic peptide as diagnostic markers of neonatal infection.
    Cao Y; Xia Q; Chen C; Yang Y
    Acta Paediatr; 2012 Mar; 101(3):242-6. PubMed ID: 22053979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
    Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
    Odermatt J; Meili M; Hersberger L; Bolliger R; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
    BMC Cardiovasc Disord; 2017 Jul; 17(1):178. PubMed ID: 28676115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.